Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.

Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.

IMPORTANCE: Neuromyelitis optica (NMO) is an inflammatory disease of the optic nerves and spinal cord that leads to blindness and paralysis. Effective immunosuppression is the standard of care for relapse prevention. OBJECTIVE: To compare the relapse and treatment failure rates among patients receiv...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Mealy, M, Wingerchuk, D, Palace, J, Greenberg, B, Levy, M
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	2014

Antzeko izenburuak

Treatment of Neuromyelitis Optica: Review and Recommendations.
nork: Kimbrough, D, et al.
Argitaratua: (2012)

Treatment of neuromyelitis optica: Review and recommendations
nork: Kimbrough, D, et al.
Argitaratua: (2012)

Neuromyelitis optica relapses: race and rate, immunosuppression and impairment
nork: Tackley, G, et al.
Argitaratua: (2016)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
nork: Elsone, L, et al.
Argitaratua: (2012)

B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20
nork: Levy M, et al.
Argitaratua: (2021-08-01)

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.
nork: Palace, J, et al.
Argitaratua: (2010)

Seasonal pattern of variation in neuromyelitis optica relapses
nork: Elsone, L, et al.
Argitaratua: (2012)

A practical guide to the treatment of neuromyelitis optica.
nork: Palace, J, et al.
Argitaratua: (2012)

A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder
nork: Achim Berthele, et al.
Argitaratua: (2023-04-01)

Prognosis of Relapsing Neuromyelitis Optica
nork: J Gordon Millichap
Argitaratua: (2003-03-01)

Relapsing neuromyelitis optica spectrum disorder
nork: M Lakshmi Lavanya, et al.
Argitaratua: (2021-01-01)

The borderland of neuromyelitis optica.
nork: Matthews, L, et al.
Argitaratua: (2009)

Good response to Ofatumumab in a child with severe relapsing Neuromyelitis Optica
nork: Sedani, S, et al.
Argitaratua: (2012)

Racial differences in neuromyelitis optica spectrum disorder
nork: Kim, S, et al.
Argitaratua: (2018)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
nork: Kitley, J, et al.
Argitaratua: (2014)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
nork: Kitley, J, et al.
Argitaratua: (2014)

Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
nork: Pittock, S, et al.
Argitaratua: (2019)

Use of mitoxantrone in neuromyelitis optica.
nork: Kitley, J, et al.
Argitaratua: (2011)

Treatment strategies for neuromyelitis optica
nork: Tzu-Lun Huang, et al.
Argitaratua: (2018-01-01)

Magnetic resonance imaging in neuromyelitis optica.
nork: Tackley, G, et al.
Argitaratua: (2014)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
nork: Waters, P, et al.
Argitaratua: (2015)

Observation of the efficacy of ofatumumab in the treatment of neuromyelitis optica spectrum disorders
nork: ZHANG Rui, et al.
Argitaratua: (2024-06-01)

Efficacy and safety of tacrolimus treatment for neuromyelitis optica spectrum disorder
nork: Bo Chen, et al.
Argitaratua: (2017-04-01)

Advances in the long-term treatment of neuromyelitis optica spectrum disorder
nork: Monique Anderson, et al.
Argitaratua: (2024-01-01)

The evolving clinical spectrum of neuromyelitis optica
nork: Viegas, S, et al.
Argitaratua: (2008)

Clinical evaluation of rituximab treatment for neuromyelitis optica
nork: M.J. Fernández-Megía, et al.
Argitaratua: (2015-10-01)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
nork: Matthews, L, et al.
Argitaratua: (2014)

Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.
nork: Fujihara, K, et al.
Argitaratua: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
nork: Matthews, L, et al.
Argitaratua: (2013)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
nork: Waters, P, et al.
Argitaratua: (2016)

Treatment response, risk of relapse and clinical characteristics of Taiwanese patients with neuromyelitis optica spectrum disorder
nork: Yi-Hong Liu, et al.
Argitaratua: (2022-09-01)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
nork: Collongues, N, et al.
Argitaratua: (2013)

Relapse of Neuromyelitis Optica Spectrum Disorder Associated with Intravenous Lidocaine
nork: Akiyuki Uzawa, et al.
Argitaratua: (2011-01-01)

Seasonality of 278 neuromyelitis optica relapses in a Brazilian cohort
nork: Denis Bernardi Bichuetti, et al.
Argitaratua: (2015-02-01)

Review: Treatment of neuromyelitis optica: Current debate
nork: Tomoko Okamoto, et al.
Argitaratua: (2008-07-01)

Treatment of neuromyelitis optica: an evidence based review
nork: Douglas Sato, et al.
Argitaratua: (2012-01-01)

Current and future treatment approaches for neuromyelitis optica
nork: Nicolas Collongues, et al.
Argitaratua: (2011-03-01)

A mathematical model of cellular swelling in Neuromyelitis optica
nork: Laranjeira, S, et al.
Argitaratua: (2017)

Neuromyelitis Optica
nork: Goyal V, et al.
Argitaratua: (2009-10-01)

Neuromyelitis optica
nork: Jacob Anu, et al.
Argitaratua: (2007-01-01)